3859 results for «2347»

Filter By

3859 results

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

TAV-in-TAV in SAV 3 valves procedures

21 May 2025 – From EuroPCR 2025

Examine the complexities of TAV-in-TAV procedures in degenerated surgical aortic valves (SAV) and TAVI valves. This session discusses cases involving massive aortic regurgitation, lifetime management challenges, and valve-in-valve-in-valve scenarios, providing practical insights into managing multiple valve interventions and associated complications.

TAV-in-TAV in SAV 3 valves procedures

Coils and plugs for coronary intervention

21 May 2025 – From EuroPCR 2025

This session highlights the use of coils and plugs in complex coronary interventions. Through unique case presentations, it covers diagnosis and management of unusual cardiac masses, recurrent fistulas, and rare causes of angina, illustrating innovative device applications in challenging coronary anatomy and post-surgical scenarios.

Coils and plugs for coronary intervention

Current DCB practice: from lesion preparation to follow-up

21 May 2025 – From EuroPCR 2025

Explore current best practices in drug-coated balloon (DCB) angioplasty from lesion preparation to follow-up. This session discusses common indications, management of dissections and complications, and shares practical tips and case examples, equipping clinicians with comprehensive knowledge to optimize DCB use in contemporary PCI.

Current DCB practice: from lesion preparation to follow-up

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

21 May 2025 – From EuroPCR 2025

Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.

TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3

How imaging can improve efficiency in CTO PCI

21 May 2025 – From EuroPCR 2025

Discover how advanced imaging techniques improve efficiency in CTO PCI procedures. This session features IVUS-guided antegrade dissection, angio-CT guided retrograde recanalisation, and complex cases involving anomalous anatomy and multiple bifurcations.

How imaging can improve efficiency in CTO PCI

Calcified lesions: preparing for the battlefield

21 May 2025 – From EuroPCR 2025

Prepare to tackle calcified coronary lesions with expertise in imaging interpretation and calcium modification tools. This session covers IVUS and OCT use, preparation techniques, and enhancing team communication to optimize procedural outcomes in complex cases.

Calcified lesions: preparing for the battlefield

Bifurcation stenting techniques outcomes

21 May 2025 – From EuroPCR 2025

Examine the outcomes of various bifurcation stenting techniques with insights from multiple registries and trials. This session compares guidance methods and evaluates clinical results of double kissing culotte, nano-crush, POKI, and DK crush techniques in different lesion settings.

Bifurcation stenting techniques outcomes

Challenging STEMI cases: unwanted situations

21 May 2025 – From EuroPCR 2025

Address challenging STEMI cases involving multivessel disease, high thrombus burden, and spontaneous coronary artery dissection. This session provides case-based learning on managing unexpected scenarios, diagnostic approaches, and tailored treatment strategies in complex STEMI presentations.

Challenging STEMI cases: unwanted situations

How to treat - DCB

21 May 2025 – From EuroPCR 2025

Explore drug-coated balloon (DCB) therapy through detailed case studies covering calcified vessels, small diffuse vessel disease, and de novo ostial lesions. Gain practical insights on treatment approaches and key learning points to enhance your DCB practice.

How to treat - DCB

Challenging scenarios in the pulmonary system - Part 1

21 May 2025 – From EuroPCR 2025

This session presents challenging pulmonary system cases including high-risk and intermediate-high risk pulmonary embolism, complex congenital heart disease, and rare cardiac conditions. Understand critical management strategies for these uncommon but urgent scenarios.

Challenging scenarios in the pulmonary system - Part 1

Improving outcomes of NSTEMI patients

21 May 2025 – From EuroPCR 2025

Review contemporary evidence on improving outcomes for NSTEMI patients. Topics include the effects of evolocumab on stent coverage, impact of left ventricular function with kidney disease, GRACE score-based outcomes, PCI timing, and early initiation of Tafolecimab.

Improving outcomes of NSTEMI patients

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

21 May 2025 – From EuroPCR 2025

This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.

Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously

Challenging clinical scenarios in coronary artery disease

21 May 2025 – From EuroPCR 2025

Confront challenging clinical scenarios in coronary artery disease with case-based discussions. Topics include managing multiple stent layers, late mediastinal hematoma, PCI optimization through physiology and imaging, refractory angina treatment, and acute tamponade management.

Challenging clinical scenarios in coronary artery disease

How to deal with left main culprit in NSTEMI

21 May 2025 – From EuroPCR 2025

This session offers a cross-geographic exchange on managing left main culprit lesions in NSTEMI patients. Learn different interventional approaches, risk evaluation for periprocedural complications, and diverse PCI management strategies tailored to this complex subgroup.

How to deal with left main culprit in NSTEMI

TAVI for bioprosthetic valve failure - LIVE Case

22 May 2025 – From EuroPCR 2025

A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...

TAVI for bioprosthetic valve failure - LIVE Case

Therapeutic choices for TTVIV-TTVIR interventions

21 May 2025 – From EuroPCR 2025

Explore therapeutic choices for transcatheter tricuspid valve-in-valve and valve-in-ring interventions. Case studies cover annular ring expansion, pacing-related infection, jugular vein access valve replacement, Ebstein anomaly, and double valve-in-valve procedures in right heart disease.

Therapeutic choices for TTVIV-TTVIR interventions

Antiplatelet strategies for clinical dilemmas

22 May 2025 – From EuroPCR 2025

Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...

Antiplatelet strategies for clinical dilemmas

TAVI in women

22 May 2025 – From EuroPCR 2025

Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...

TAVI in women

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?
Didn’t find what you were looking for?